title: Rapid HIV antibody testing in the New York State Anonymous HIV Counseling and Testing Program: experience from the field.
abstract: OBJECTIVE
  To assess rapid and conventional HIV test use, client satisfaction, and counselors' comfort.
  
  
  METHODS
  At 61 HIV test sites in New York State, we compared HIV test use during the first 6 months of rapid testing in 2003 with the same time period in 2002. We administered surveys to clients at each site during the first 30 days of rapid testing and to counselors before and after training and after 12 weeks of using rapid tests in the field.
  
  
  RESULTS
  Almost all (1249 [96.5%] of 1294) clients surveyed selected rapid over conventional HIV testing. During the evaluation period, 6187 HIV tests were reported, 1667 (36.9%) more than during the same period in 2002. All 5771 (100%) of 5771 clients received their rapid HIV test results compared with 333 (85.8%) of 388 clients (P < 0.0001) who had elected conventional testing. After performing rapid testing for 12 weeks, 32 (80%) of 40 trained counselors reported feeling "very comfortable" delivering reactive rapid test results compared with 14 (35%) of 40 trained counselors (P < 0.001) before training.
  
  
  CONCLUSIONS
  Rapid testing presents a key opportunity to increase the number of people undergoing HIV testing and the proportion receiving their test results.
authors.affiliation: New York State Department of Health AIDS Institute, Corning Tower Rm. 315, Albany, NY 12237, USA. mls07@health.state.ny.us
authors.forename: Mara
authors.initials: M
authors.lastname: San Antonio-Gaddy
authors.forename: April
authors.initials: A
authors.lastname: Richardson-Moore
authors.forename: Gale R
authors.initials: GR
authors.lastname: Burstein
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Newman
authors.forename: Bernard M
authors.initials: BM
authors.lastname: Branson
authors.forename: Guthrie S
authors.initials: GS
authors.lastname: Birkhead
mesh_terms: D015492:AIDS Serodiagnosis; D035041:Anonymous Testing; D003376:Counseling; D005260:Female; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000175:diagnosis* / Q000276:immunology; D015497:HIV-1 / Q000276:immunology; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008403:Mass Screening; D009518:New York; D015397:Program Evaluation; D011933:Reagent Kits, Diagnostic; D013997:Time Factors
chemical_list: D015483:HIV Antibodies; D011933:Reagent Kits, Diagnostic